Neuropsychological assessment of substance abusers: review and recommendations.
paper
Cited
Public
Unavailable
- Authors
- Miller, L
- Year
- 1985
- Journal
- Journal of substance abuse treatment
- PMID
- 3900432
- DOI
- 10.1016/0740-5472(85)90017-0
Neuropsychological assessment of substance abusers frequently proves useful for the evaluation of those aspects of cognitive functioning that may be relevant for optimal therapeutic management and treatment planning. Research has demonstrated the presence of neuropsychological impairment in chronic abusers of CNS depressants, including alcohol, as well as opiates and possibly cocaine, especially when such substances are combined in a polydrug pattern of abuse. Clinical neuropsychological evaluation of individual substance abusers should take into account the various personal, demographic and neuromedical background variables that can affect cognitive functioning. Efforts should be made to distinguish between acute drug effects and more longterm stable deficits that may not become apparent for some time. Neuropsychological referrals should be made, and measures selected to answer particular questions about neurocognitive functioning that are relevant to treatment and eventual overall adjustment. A neuropsychological review of systems is likely to show a pattern of impairment in substance abusers that involves the integration of different cognitive functions for effective problem solving. Strongly focal or lateralized deficit patterns are less likely to be the result of drug abuse alone, and should prompt the appropriate neuromedical follow-up.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Event-Related Oscillations in Alcoholism Research: A Review. | 2012 | 24273686 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Cognitive impairment as a predictor of long-term psychological distress in patients with polysubstance use disorders: a prospective longitudinal cohort study. | Hetland J et al. | — | 2024 | → |
| No evidence of accelerated epigenetic aging among black heroin users: A case vs control analysis. | Jones JD et al. | — | 2023 | → |
| Performance on Cognitive Screening Tests and Long-Term Substance Use Outcomes in Patients with Polysubstance Use Disorder. | Hetland J et al. | — | 2023 | → |
| Prevalence and Characteristics of Borderline Intellectual Functioning in a Cohort of Patients With Polysubstance Use Disorder. | Hetland J et al. | — | 2021 | → |
| Imaging Cortical Dopamine Transmission in Cocaine Dependence: A [<sup>11</sup>C]FLB 457-Amphetamine Positron Emission Tomography Study. | Narendran R et al. | — | 2020 | → |
| Measuring cognitive impairment in young adults with polysubstance use disorder with MoCA or BRIEF-A - The significance of psychiatric symptoms. | Hagen E et al. | — | 2019 | → |
| Telehealth interventions to reduce alcohol use in men with HIV who have sex with men: Protocol for a factorial randomized controlled trial. | Kahler CW et al. | — | 2019 | → |
| One-year abstinence improves ADHD symptoms among patients with polysubstance use disorder. | Hagen E et al. | — | 2017 | → |
| One-year sobriety improves satisfaction with life, executive functions and psychological distress among patients with polysubstance use disorder. | Hagen E et al. | — | 2017 | → |
| Resting-State Neuroimaging and Neuropsychological Findings in Opioid Use Disorder during Abstinence: A Review. | Ieong HF et al. | — | 2017 | → |
| Assessment of Executive Function in Patients With Substance Use Disorder: A Comparison of Inventory- and Performance-Based Assessment. | Hagen E et al. | — | 2016 | → |
| Assessment of Cognitive Functions in Methadone Maintenance Patients. | Mazhari S et al. | — | 2015 | → |
| Repeated cocaine exposure increases fast-spiking interneuron excitability in the rat medial prefrontal cortex. | Campanac E et al. | — | 2013 | → |
| The effect of AM281, a cannabinoid antagonist, on memory performance during spontaneous morphine withdrawal in mice. | Vaseghi G et al. | — | 2013 | → |
| Effects of cognitive impairment on substance abuse treatment attendance: predictive validation of a brief cognitive screening measure. | Copersino ML et al. | — | 2012 | → |
| Event-Related Oscillations in Alcoholism Research: A Review. | Pandey AK et al. | — | 2012 | → |
| Neuropsychological consequences of chronic opioid use: a quantitative review and meta-analysis. | Baldacchino A et al. | — | 2012 | → |
| Structural deficits in the emotion circuit and cerebellum are associated with depression, anxiety and cognitive dysfunction in methadone maintenance patients: a voxel-based morphometric study. | Lin WC et al. | — | 2012 | → |
| Specificity of verbal learning impairment and recovery in a marijuana-dependent male: the effects of sustained marijuana abstinence. | Vadhan NP et al. | — | 2011 | → |
| Contributors to neuropsychological impairment in HIV-infected and HIV-uninfected opiate-dependent patients. | Applebaum AJ et al. | — | 2010 | → |
| Rapid cognitive screening of patients with substance use disorders. | Copersino ML et al. | — | 2009 | → |
| The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients. | Applebaum AJ et al. | — | 2009 | → |
| Chronic administration of heroin to mice produces up-regulation of brain apoptosis-related proteins and impairs spatial learning and memory. | Tramullas M et al. | — | 2008 | → |
| Metyrapone and mifepristone reverse recognition memory loss induced by spontaneous morphine withdrawal in mice. | Mesripour A et al. | — | 2008 | → |
| Persistent alterations in cognitive function and prefrontal dopamine D2 receptors following extended, but not limited, access to self-administered cocaine. | Briand LA et al. | — | 2008 | → |
| Verbal working memory deficits in abstinent heroin abusers. | Wang ZX et al. | — | 2008 | → |
| High suicide risk after the development of cognitive and working memory deficits caused by cannabis, cocaine and ecstasy use. | Pompili M et al. | — | 2007 | → |
| Assessment of cognitive functioning of methadone-maintenance patients: impact of adult ADHD and current cocaine dependence. | Brooks DJ et al. | — | 2006 | → |
| Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment. | Prosser J et al. | — | 2006 | → |
| The detection of cognitive impairment among substance-abusing patients: the accuracy of the neuropsychological assessment battery-screening module. | Grohman K et al. | — | 2004 | → |
| The role of brain oscillations as functional correlates of cognitive systems: a study of frontal inhibitory control in alcoholism. | Kamarajan C et al. | — | 2004 | → |
| Anxiety and trail making test scores in a sample of cocaine abusers. | Roberts C et al. | — | 2003 | → |
| Depression and trail making test scores in a sample of cocaine abusers. | Horton AM et al. | — | 2003 | → |
| Derived trail making test indices in a sample of alcohol abusers: demographic effects. | Roberts C et al. | — | 2002 | → |
| Derived Trail Making Test indices in a sample of amphetamine abusers: demographic effects. | Roberts C et al. | — | 2002 | → |
| Derived trail making test indices in a sample of hallucinogen abusers: demographic effects. | Horton AM et al. | — | 2002 | → |
| Derived trail making test indices in a sample of heroin abusers: demographic effects. | Horton AM et al. | — | 2002 | → |
| Derived trail making test indices in a sample of narcotic/other opiate abusers: demographic effects. | Horton AM et al. | — | 2002 | → |
| Substance abuse treatment outcomes for cognitively impaired and intact outpatients. | Teichner G et al. | — | 2002 | → |
| Demographic effects on the Trail Making test in alcohol abusers. | Horton AM et al. | — | 2001 | → |
| Demographic variables and microCog performance: relationships for VA patients under treatment for substance abuse. | Lopez SJ et al. | — | 2001 | → |
| Derived trail making test indices in a sample of substance abusers: demographic effects. | Horton AM et al. | — | 2001 | → |
| Neuropsychological predictors of the attainment of treatment objectives in substance abuse patients. | Teichner G et al. | — | 2001 | → |
| Sex, ethnicity, age and education effects on the Trail Making test in a sample of cocaine abusers. | Horton AM et al. | — | 2001 | → |
| Sex, ethnicity, age and education effects on the Trail Making Test in a sample of heroin abusers. | Roberts C et al. | — | 2001 | → |
| Using the Trail Making test to screen for cognitive impairment in a drug abuse treatment sample. | Roberts C et al. | — | 2001 | → |
| Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users. | Parrott AC et al. | — | 2000 | → |
| Attentional functioning in abstinent cocaine abusers. | Horner MD | — | 1999 | → |
| Self-report and objective measures of cognitive deficit in patients entering substance abuse treatment. | Horner MD et al. | — | 1999 | → |
| Neurobiology of cocaine-induced organic brain impairment: contributions from functional neuroimaging. | Strickland TL et al. | — | 1998 | → |
| Cognitive impairment among the dually-diagnosed: substance use history and depressive symptom correlates. | Carpenter KM et al. | — | 1997 | → |
| The use of a mental status examination in a chemical dependence treatment program. | Anderson DA et al. | — | 1997 | → |
| Behavioral and cognitive measurements predict scores on the MAST: a 3-year prospective study. | Deckel AW et al. | — | 1996 | → |
| Intermediate length neuropsychological screening of impairment among psychoactive substance-abusing patients: a comparison of two batteries. | Fals-Stewart W | — | 1996 | → |
| Anterior brain dysfunctioning as a risk factor in alcoholic behaviors. | Deckel AW et al. | — | 1995 | → |
| Effects of early adolescent drug use on cognitive efficacy in early-late adolescence: a developmental structural model. | Scheier LM et al. | — | 1995 | → |
| The relationship of patients' cognitive status and therapists' ratings of psychological distress among psychoactive substance users in long-term residential treatment. | Fals-Stewart W et al. | — | 1995 | → |
| Effect of substance abuse on visuographic function. | Amir T et al. | — | 1994 | → |
| Cerebral perfusion and neuropsychological consequences of chronic cocaine use. | Strickland TL et al. | — | 1993 | → |
| Neuropsychology, personality, and substance abuse in the head injury case: clinical and forensic issues. | Miller L | — | 1992 | → |
| The relationship between length of stay in drug-free therapeutic communities and neurocognitive functioning. | Fals-Stewart W et al. | — | 1992 | → |
| Use of the Dementia Rating Scale as a test for neuropsychological dysfunction in HIV-positive i.v. drug abusers. | Kovner R et al. | — | 1992 | → |
| Using subtests of the Brain Age Quotient to screen for cognitive deficits among substance abusers. | Fals-Stewart W | — | 1992 | → |
| Brain and self: toward a neuropsychodynamic model of ego autonomy and personality. | Miller L | — | 1991 | → |
| Predicting relapse and recovery in alcoholism and addiction: neuropsychology, personality, and cognitive style. | Miller L | — | 1991 | → |
| Concurrent and simultaneous use of alcohol with cocaine: results of national survey. | Grant BF et al. | — | 1990 | → |
| Concurrent and simultaneous use of alcohol with sedatives and with tranquilizers: results of a national survey. | Grant BF et al. | — | 1990 | → |
| Neuropsychodynamics of alcoholism and addiction: personality, psychopathology, and cognitive style. | Miller L | — | 1990 | → |
| Neurocognitive impairment: the unrecognized component of dual diagnosis in substance abuse treatment. | Meek PS et al. | — | 1989 | → |
| Neuropsychologically impaired alcoholics: assessment, treatment considerations, and rehabilitation. | Gordon SM et al. | — | 1988 | → |
| 'Narrow localizationism' in psychiatric neuropsychology. | Miller L | — | 1986 | → |